BioSpace News Archive

Biotech Beach

Amgen Update: No “Significant Delays” from COVID-19 Pandemic for KRAS Inhibitor

Like many biopharma companies, Amgen is evaluating how the COVID-19 pandemic is affecting its operations, supply chain and clinical trial programs.

March 31, 2020
·
2 min read
·
Mark Terry
Genetown

In Other (Biopharma) News: Non-Coronavirus Stories this Week

The following is a roundup of some of this week’s non-coronavirus biopharma news.

March 31, 2020
·
5 min read
·
Alex Keown
Business

Charles River and Deciphex Strike Digital Pathology Deal

Under terms of the agreement, Charles River Laboratories will be able to provide its clients with the use of Deciphex’s flagship product.

March 31, 2020
·
2 min read
·
Alex Keown
Career Advice

4 Ways to Improve Your Productivity While Working From Home

Here are four ways to improve your productivity while working from home!

March 31, 2020
·
3 min read
·
Porschia Parker-Griffin
Business

Could a 100-Year-Old Tuberculosis Vaccine Help Prevent COVID-19?

Results from the trial, which will begin dosing on April 6, aren’t likely until September.

March 31, 2020
·
2 min read
·
Mark Terry
Newly published data in Cancer Immunology, Immunotherapy support the potential of Secarna Pharmaceuticals’ LNA-modified ASOs to effectively block important immunosuppressive pathway

Secarna’s approach efficiently targets IDO1 and TDO2, key enzymes that degrade the essential amino acid tryptophan into immunosuppressive kynurenine

March 31, 2020
·
5 min read
Business

3SBio Unveils 2019 Annual Results: Revenue Rises by 16.0%, Normalized Net Profit attributable to owners of the parent Jumps by19.4%, R&D Expenses Soar 45.2%

Chinese leading biopharmaceutical company 3SBio released its 2019 annual results, showing that the Company maintained steady growth, with core products continuously leading the market and more products being included into drug reimbursement lists.

March 31, 2020
·
7 min read
Update on 92nd Vifor Pharma Ltd. Annual General Meeting

Vifor Pharma confirmed that it will hold its Annual General Meeting on 14 May, 2020, as planned.

March 31, 2020
·
2 min read
Myovant Sciences and Gedeon Richter Enter into Exclusive License Agreement to Commercialize Relugolix Combination Tablet for Uterine Fibroids and Endometriosis in Certain Territories Outside the U.S.

Gedeon Richter to commercialize relugolix combination tablet for uterine fibroids and endometriosis in Europe, Russia - CIS, Latin America, Australia, and New Zealand

March 31, 2020
·
9 min read
Verona Pharma Reports Positive Efficacy and Safety Data with Single Dose pMDI Formulation of Ensifentrine in COPD

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces positive efficacy and safety data with a single dose of pressurized metered-dose inhaler formulation of ensifentrine in a Phase 2 clinical trial in patients with moderate to severe chronic obstructive pulmonary disease.

March 31, 2020
·
9 min read